Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | -0.75% | +22.22% | +17.86% |
02:28pm | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
02:16pm | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.86% | 5.03Cr | |
+5.33% | 11TCr | |
+12.11% | 11TCr | |
-12.56% | 2.22TCr | |
-3.38% | 2.13TCr | |
-5.85% | 1.9TCr | |
-35.21% | 1.85TCr | |
-10.86% | 1.68TCr | |
+37.57% | 1.25TCr | |
-26.24% | 808.97Cr |
- Stock Market
- Equities
- BOLT Stock
- News Bolt Biotherapeutics, Inc.
- SVB Securities Upgrades Bolt Biotherapeutics to Outperform From Market Perform, Price Target is $4